XORTX Therapeutics (XRTX) Amortization - Intangibles (2021 - 2026)

XORTX Therapeutics' Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $3460.0 for Q1 2026.

• Quarterly Amortization - Intangibles changed N/A year-over-year to $3460.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23166.0 (changed N/A YoY) and the FY2025 annual result came in at $26385.0, down 15.08% from the prior year.
• Amortization - Intangibles was $3460.0 for Q1 2026 at XORTX Therapeutics, down from $6578.0 in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $36054.3 in Q1 2023 and bottomed at -$40041.0 in Q4 2023.
• A 5-year average of $5087.1 and a median of $6497.0 in 2025 frame the typical range for Amortization - Intangibles.
• Peak annual rise in Amortization - Intangibles reached 1109.45% in 2023, while the deepest fall reached 1050.04% in 2023.
• XORTX Therapeutics' Amortization - Intangibles stood at $4214.7 in 2022, then slumped by 1050.04% to -$40041.0 in 2023, then surged by 116.56% to $6631.0 in 2024, then retreated by 0.8% to $6578.0 in 2025, then plunged by 47.4% to $3460.0 in 2026.
• Business Quant data shows XRTX's Amortization - Intangibles at $3460.0 in Q1 2026, $6578.0 in Q4 2025, and $6497.0 in Q3 2025.